跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Kodabact
Approved
STANDARD
Kodabact
Opal Laboratories (Pvt.) Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9def386bf871274e
Company
Opal Laboratories (Pvt.) Limited
Type
Standard
Approval Details
Approval Id
9def386bf871274e
Drug Approval Philippines Name
Kodabact
Product Name
Kodabact
Registration Number
DRP-12991-01
Brand Name
Kodabact
Generic Name
Mupirocin
Dosage Form
Topical Ointment
Dosage Strength
20mg/g (2% w/w)
Manufacturer
Opal Laboratories (Pvt.) Limited
Importer
Accesspoint International Trading Inc
Distributor
Kodapharm Med Corp.
Issuance Date
29 May 2023
Expiry Date
14 November 2027
Pharmacologic Category
Antibacterial
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9def386bf871274e
Type
Standard
Back to Philippines FDA Approvals
Kodabact - Philippines FDA Drug Approval Details